Physician profile
James D Smith
NPI 1568886406
$2,856.56
in general payments reported to CMS, 2019-2025
17 companies · $721 in 2025
The $721 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $435 · 2022: $540 · 2023: $650 · 2024: $510 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,681.35 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $683.04 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $552.25 | 2021-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $377.21 | 2022-2025 | |
| Abbvie INC. | $260.50 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $255.01 | 2021-2024 | Dupixent |
| Ucb, INC. | $248.45 | 2021-2025 | Bimzelx |
| Paratek Pharmaceuticals, INC. | $94.17 | 2024-2025 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $82.26 | 2022-2025 | Sotyktu |
| Medtronic, INC. | $75.48 | 2021 | |
| Allergan, INC. | $44.64 | 2022 | |
| Amgen INC. | $38.47 | 2024-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $37.82 | 2023 | Oracea, Aklief, Epsolay |
| Genzyme Corporation | $32.82 | 2025 | |
| Incyte Corporation | $26.01 | 2024 | Opzelura |
| Sun Pharmaceutical Industries INC. | $18.39 | 2023 | Odomzo, Blu-U |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.74 | 2023 | |
| Organon LLC | $14.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.